Keith Murphy - Organovo Holdings Chairman
| ONVO Stock | USD 0.34 0.01 2.86% |
Chairman
Mr. Keith E. Murphy is Chairman of the Board of Organovo Holdings Inc. Mr. Murphy is one of the Companys founders and has served as our President, Chief Executive Officer and Chairman since joining the Company in July 2007, and since April 2016, has served as our Principal Financial Officer and Principal Accounting Officer since 2017.
| Age | 53 |
| Tenure | 8 years |
| Address | 11555 Sorrento Valley Road, San Diego, CA, United States, 92121 |
| Phone | 858 224 1000 |
| Web | https://www.organovo.com |
Keith Murphy Latest Insider Activity
Tracking and analyzing the buying and selling activities of Keith Murphy against Organovo Holdings stock is an integral part of due diligence when investing in Organovo Holdings. Keith Murphy insider activity provides valuable insight into whether Organovo Holdings is net buyers or sellers over its current business cycle. Note, Organovo Holdings insiders must abide by specific rules, including filing SEC forms every time they buy or sell Organovo Holdings'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Keith Murphy over three months ago Acquisition by Keith Murphy of 19607 shares of Organovo Holdings subject to Rule 16b-3 | ||
Keith Murphy over six months ago Acquisition by Keith Murphy of 143731 shares of Organovo Holdings at 0.5368 subject to Rule 16b-3 | ||
Keith Murphy over a year ago Acquisition by Keith Murphy of 19607 shares of Organovo Holdings subject to Rule 16b-3 |
Organovo Holdings Management Efficiency
The company has return on total asset (ROA) of (0.891) % which means that it has lost $0.891 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.0669) %, meaning that it created substantial loss on money invested by shareholders. Organovo Holdings' management efficiency ratios could be used to measure how well Organovo Holdings manages its routine affairs as well as how well it operates its assets and liabilities. As of the 6th of February 2025, Return On Equity is likely to grow to 8.62, while Return On Tangible Assets are likely to drop (2.75). At this time, Organovo Holdings' Other Current Assets are very stable compared to the past year. As of the 6th of February 2025, Other Assets is likely to grow to about 778.8 K, while Total Assets are likely to drop about 6.9 M.Similar Executives
| Found 3 records | CHAIRMAN Age | ||
| Archie Black | Proto Labs | 58 | |
| Sven Wehrwein | Proto Labs | 69 | |
| Charles McClure | 3D Systems | 67 | |
Management Performance
| Return On Equity | -2.07 | ||||
| Return On Asset | -0.89 |
Organovo Holdings Leadership Team
Elected by the shareholders, the Organovo Holdings' board of directors comprises two types of representatives: Organovo Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Organovo. The board's role is to monitor Organovo Holdings' management team and ensure that shareholders' interests are well served. Organovo Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Organovo Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Keith Murphy, Chairman, CEO and President Member of Audit Committee and Member of Science and Technology Committee | ||
| Norman Staskey, CFO President | ||
| Vaidehi Joshi, Director Director | ||
| MS JD, Gen Sec | ||
| Curtis Tyree, Senior Development | ||
| Jeffrey Miner, Chief Officer |
Organovo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Organovo Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.07 | ||||
| Return On Asset | -0.89 | ||||
| Operating Margin | (86.93) % | ||||
| Current Valuation | 3.2 M | ||||
| Shares Outstanding | 15.37 M | ||||
| Shares Owned By Insiders | 2.02 % | ||||
| Shares Owned By Institutions | 15.88 % | ||||
| Number Of Shares Shorted | 78.04 K | ||||
| Price To Earning | (3.67) X | ||||
| Price To Book | 1.41 X |
Pair Trading with Organovo Holdings
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Organovo Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organovo Holdings will appreciate offsetting losses from the drop in the long position's value.Moving against Organovo Stock
The ability to find closely correlated positions to Organovo Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Organovo Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Organovo Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Organovo Holdings to buy it.
The correlation of Organovo Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Organovo Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Organovo Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Organovo Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organovo Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Organovo Stock, please use our How to Invest in Organovo Holdings guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organovo Holdings. If investors know Organovo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organovo Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.04) | Revenue Per Share | Quarterly Revenue Growth (0.48) | Return On Assets | Return On Equity |
The market value of Organovo Holdings is measured differently than its book value, which is the value of Organovo that is recorded on the company's balance sheet. Investors also form their own opinion of Organovo Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organovo Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organovo Holdings' market value can be influenced by many factors that don't directly affect Organovo Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organovo Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organovo Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organovo Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.